Bionaturis Group will take part in the BIOMAP consortium, devoted to the multivariate design of assays, with the ultimate goal of developing biomedicines using the pharmaceutical criteria for quality, security and efficacy designs (Quality by design or QbD).

Bionaturis will receive an incentive of 572.988€ from the Feder-Interconecta Programme, administrated by the CDTI.

For the official disclosing, please click here